1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with Hyperoxia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benipal, B; Chatterjee, S; Dodia, C; Feinstein, SI; Fisher, AB | 1 |
1 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Hyperoxia
| Article | Year |
|---|---|
Inhibition of the phospholipase A2 activity of peroxiredoxin 6 prevents lung damage with exposure to hyperoxia.
Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Gene Expression Regulation; Glycerophosphates; Hyperoxia; Injections, Intraperitoneal; Lipid Peroxidation; Lung; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Oxidative Stress; Oxygen; Peroxiredoxin VI; Phospholipase A2 Inhibitors; Phospholipases A2; Reactive Oxygen Species; Signal Transduction | 2015 |